Publications

  1. Nathoo N, Larson DP, Guo Y, Giannini C, Lucchinetti CF, Micallef IN, Rech KL, Jevremovic D, Lachance DH, Abeykoon JP, Go RS, Tobin WO. Central nervous system crystal-storing histiocytosis: A case report and literature review. Eur J Neurol. 2024 Oct 25; e16528 [Epub ahead of print]
    View PubMed
  2. Gakh O, Wilkins JM, Guo Y, Popescu BF, Weigand SD, Kalinowska-Lyszczarz A, Lucchinetti CF. Infrared spectral profiling of demyelinating activity in multiple sclerosis brain tissue. Acta Neuropathol Commun. 2024 Sep 10; 12 (1):146 Epub 2024 Sept 10
    View PubMed
  3. Syc-Mazurek SB, Zhao-Fleming H, Guo Y, Tisavipat N, Chen JJ, Zekeridou A, Kournoutas I, Orme JJ, Block MS, Lucchinetti CF, Mustafa R, Flanagan EP. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use. Neurol Neuroimmunol Neuroinflamm. 2024 Jul; 11 (4):e200249 Epub 2024 May 02
    View PubMed
  4. Gupta P, Paul P, Redenbaugh V, Guo Y, Lucchinetti C, Abdulrahman Y, Datta A, Shah S, Klein CJ, Pittock SJ, Flanagan EP, Dubey D. Peripheral nervous system manifestations of MOG antibody associated disease. Ann Clin Transl Neurol. 2024 Apr; 11 (4):1046-1052 Epub 2024 Jan 17
    View PubMed
  5. Guo Y, Endmayr V, Zekeridou A, McKeon A, Leypoldt F, Hess K, Kalinowska-Lyszczarz A, Klang A, Pakozdy A, Hoftberger E, Hametner S, Haider C, De Simoni D, Peters S, Gelpi E, Rocken C, Oberndorfer S, Lassmann H, Lucchinetti CF, Hoftberger R. New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis. Acta Neuropathol. 2024 Feb 3; 147 (1):31 Epub 2024 Feb 03
    View PubMed
  6. Wilkins JM, Mangalaparthi KK, Netzel BC, Sherman WA, Guo Y, Kalinowska-Lyszczarz A, Pandey A, Lucchinetti CF. Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions. Front Mol Neurosci. 2024; 17:1448215 Epub 2024 Aug 21
    View PubMed
  7. Fereidan-Esfahani M, Decker PA, Weigand SD, Lopez Chiriboga AS, Flanagan EP, Tillema JM, Lucchinetti CF, Eckel-Passow JE, Tobin WO. Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients. Ann Clin Transl Neurol. 2023 Sep; 10 (9):1544-1555 Epub 2023 July 13
    View PubMed
  8. Yang B, Brown A, McKeon A, Ahlskog JE, Tipton P, Guo Y, Lucchinetti C, Pittock SJ, Zekeridou A. Tenascin-R Autoimmunity: Isolated Tremor Reversed with Immunotherapy. Ann Neurol. 2023 Sep; 94 (3):502-507 Epub 2023 July 14
    View PubMed
  9. Yandamuri SS, Filipek B, Obaid AH, Lele N, Thurman JM, Makhani N, Nowak RJ, Guo Y, Lucchinetti CF, Flanagan EP, Longbrake EE, O'Connor KC. MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity. JCI Insight. 2023 Jun 8; 8 (11) Epub 2023 June 08
    View PubMed
  10. Jackson-Tarlton CS, Keegan BM, Fereidan-Esfahani M, Barakat BO, Decker PA, Lucchinetti CF, Eckel-Passow J, Tobin WO. Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis. Mult Scler Relat Disord. 2023 May; 73:104614 Epub 2023 Mar 12
    View PubMed
  11. Jackson-Tarlton C, Londono D, Lucchinetti CF, Duffy DJ, Weigand SD, Tillema JM, Kalinowska-Lyszczarz A, Tobin WO. ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosis. Mult Scler Relat Disord. 2023 May; 73:104676 Epub 2023 Mar 30
    View PubMed
  12. Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, Redenbaugh V, Tillema JM, Montini F, Sechi E, Lopez-Chiriboga AS, Zalewski N, Guo Y, Rocca MA, Filippi M, Pittock SJ, Lucchinetti CF, Flanagan EP. Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 Mar 28; 100 (13):e1418-e1432 Epub 2023 Jan 23
    View PubMed
  13. Kalinowska-Lyszczarz A, Tillema JM, Tobin WO, Guo Y, Weigand SD, Metz I, Bruck W, Lassmann H, Giraldo-Chica M, Port JD, Lucchinetti CF. Long-term clinical, imaging and cognitive outcomes association with MS immunopathology. Ann Clin Transl Neurol. 2023 Mar; 10 (3):339-352 Epub 2023 Feb 09
    View PubMed
  14. Valencia-Sanchez C, Guo Y, Krecke KN, Chen JJ, Redenbaugh V, Montalvo M, Elsbernd PM, Tillema JM, Lopez-Chiriboga S, Budhram A, Sechi E, Kunchok A, Dubey D, Pittock SJ, Lucchinetti CF, Flanagan EP. Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Ann Neurol. 2023 Feb; 93 (2):297-302 Epub 2022 Dec 02
    View PubMed
  15. Wilkins JM, Gakh O, Guo Y, Popescu B, Staff NP, Lucchinetti CF. Biomolecular alterations detected in multiple sclerosis skin fibroblasts using Fourier transform infrared spectroscopy. Front Cell Neurosci. 2023; 17:1223912 Epub 2023 Sept 04
    View PubMed
  16. Syc-Mazurek SB, Chen JJ, Morris P, Sechi E, Mandrekar J, Tillema JM, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski N, Cacciaguerra L, Buciuc M, Krecke KN, Messina SA, Bhatti MT, Pittock SJ, Flanagan EP. Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody-Associated Disease. Neurology. 2022 Oct 31; 99 (18):795-799
    View PubMed
  17. Hardy TA, Guo Y, Flanagan EP, Lucchinetti CF, Tobin WO. The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions. Mult Scler. 2022 Oct; 28 (11):1710-1718 Epub 2022 May 17
    View PubMed
  18. Wingerchuk DM, Lucchinetti CF. Neuromyelitis Optica Spectrum Disorder. N Engl J Med. 2022 Aug 18; 387 (7):631-639
    View PubMed
  19. Guo Y, Lennon VA, Parisi JE, Popescu B, Vasquez C, Pittock SJ, Howe CL, Lucchinetti CF. Spectrum of sublytic astrocytopathy in neuromyelitis optica. Brain. 2022 May 24; 145 (4):1379-1390
    View PubMed
  20. Zekeridou A, Yang B, Lennon VA, Guo Y, Wu L, Lucchinetti CF, McKeon A, Pittock SJ, Flanagan EP. Anti-Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1. Ann Neurol. 2022 May; 91 (5):670-675 Epub 2022 Mar 03
    View PubMed
  21. Fereidan-Esfahani M, Decker PA, Eckel Passow JE, Lucchinetti CF, Flanagan EP, Tobin WO. Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States. Eur J Neurol. 2022 Mar; 29 (3):782-789 Epub 2021 Dec 09
    View PubMed
  22. Kalinowska-Lyszczarz A, Tillema JM, Tobin WO, Guo Y, Fitz-Gibbon PD, Weigand SD, Giraldo-Chica M, Port JD, Lucchinetti CF. Long-term clinical, MRI, and cognitive follow-up in a large cohort of pathologically confirmed, predominantly tumefactive multiple sclerosis. Mult Scler. 2022 Mar; 28 (3):441-452 Epub 2021 July 02
    View PubMed
  23. Kabiraj P, Grund EM, Clarkson BDS, Johnson RK, LaFrance-Corey RG, Lucchinetti CF, Howe CL. Teriflunomide shifts the astrocytic bioenergetic profile from oxidative metabolism to glycolysis and attenuates TNFalpha-induced inflammatory responses. Sci Rep. 2022 Feb 23; 12 (1):3049
    View PubMed
  24. Valencia-Sanchez C, Knight AM, Hammami MB, Guo Y, Mills JR, Kryzer TJ, Piquet AL, Amin A, Heinzelmann M, Lucchinetti CF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome. J Neurol Neurosurg Psychiatry. 2022 Feb; 93 (2):196-200 Epub 2021 Dec 17
    View PubMed
  25. Kalinowska-Lyszczarz A, Guo Y, Lucchinetti CF. Update on pathology of central nervous system inflammatory demyelinating diseases. Neurol Neurochir Pol. 2022; 56 (3):201-209 Epub 2022 June 27
    View PubMed
  26. Vanderdonckt P, Aloisi F, Comi G, de Bruyn A, Hartung HP, Huitinga I, Kuhlmann T, Lucchinetti CF, Metz I, Reynolds R, Lassmann H. Tissue donations for multiple sclerosis research: current state and suggestions for improvement. Brain Commun. 2022; 4 (2):fcac094 Epub 2022 Apr 19
    View PubMed
  27. Tobin WO, Kalinowska-Lyszczarz A, Weigand SD, Guo Y, Tosakulwong N, Parisi JE, Metz I, Frischer JM, Lassmann H, Bruck W, Linbo L, Lucchinetti CF. Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes. Neurology. 2021 Nov 9; 97 (19):e1906-e1913 Epub 2021 Sept 09
    View PubMed
  28. Langley MR, Choi CI, Peclat TR, Guo Y, Simon WL, Yoon H, Kleppe L, Lucchinetti CF, Chini CCS, Chini EN, Scarisbrick IA. Critical Role of Astrocyte NAD+ Glycohydrolase in Myelin Injury and Regeneration. J Neurosci. 2021 Oct 13; 41(41):8644-8667. Epub 2021 Sep 07.
    View PubMed
  29. Mustafa R, Passe TJ, Lopez-Chiriboga AS, Weinshenker BG, Krecke KN, Zalewski NL, Diehn FE, Sechi E, Mandrekar J, Kaufmann TJ, Morris PP, Pittock SJ, Toledano M, Lanzino G, Aksamit AJ, Kumar N, Lucchinetti CF, Flanagan EP. Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions. Neurol Clin Pract. 2021 Oct; 11 (5):e601-e611
    View PubMed
  30. Sechi E, Krecke KN, Messina SA, Buciuc M, Pittock SJ, Chen JJ, Weinshenker BG, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski NL, Tillema JM, Kunchok A, Monaco S, Morris PP, Fryer JP, Nguyen A, Greenwood T, Syc-Mazurek SB, Keegan BM, Flanagan EP. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders. Neurology. 2021 Sep 14; 97 (11):e1097-e1109 Epub 2021 July 14
    View PubMed
  31. Metz I, Gavrilova RH, Weigand SD, Frischer JM, Popescu BF, Guo Y, Gloth M, Tobin WO, Zalewski NL, Lassmann H, Tillema JM, Erickson BJ, Parisi JE, Becker S, Konig FB, Bruck W, Lucchinetti CF. Magnetic Resonance Imaging Correlates of Multiple Sclerosis Immunopathological Patterns. Ann Neurol. 2021 Sep; 90 (3):440-454 Epub 2021 July 19
    View PubMed
  32. Jolliffe EA, Guo Y, Hardy TA, Morris PP, Flanagan EP, Lucchinetti CF, Tobin WO. Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis. Neurology. 2021 Jul 27; 97 (4):e414-e422 Epub 2021 May 19
    View PubMed
  33. Dubey D, Kryzer T, Guo Y, Clarkson B, Cheville JC, Costello BA, Leibovich BC, Algeciras-Schimnich A, Lucchinnetti C, Hammami MB, Knight AM, Howe C, Lennon VA, McKeon A, Pittock SJ. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker. Ann Neurol. 2021 May; 89(5):1001-1010. Epub 2021 Feb 28.
    View PubMed
  34. Wilkins JM, Gakh O, Kabiraj P, McCarthy CB, Tobin WO, Howe CL, Lucchinetti CF. Correction for: Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis. Aging (Albany NY). 2021 Mar 3; 13 (5):7707 Epub 2021 Mar 03
    View PubMed
  35. Tham M, Frischer JM, Weigand SD, Fitz-Gibbon PD, Webb SM, Guo Y, Adiele RC, Robinson CA, Bruck W, Lassmann H, Furber KL, Pushie MJ, Parisi JE, Lucchinetti CF, Popescu BF. Iron Heterogeneity in Early Active Multiple Sclerosis Lesions. Ann Neurol. 2021 Mar; 89 (3):498-510 Epub 2020 Dec 19
    View PubMed
  36. Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, Tillema JM, Fryer JP, Weinshenker BG, Krecke KN, Lopez-Chiriboga AS, Nguyen A, Greenwood TM, Lucchinetti CF, Zalewski NL, Messina SA, Flanagan EP. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. 2020 Dec 28 [Epub ahead of print]
    View PubMed
  37. Lopez-Chiriboga AS, Sechi E, Buciuc M, Chen JJ, Pittock SJ, Lucchinetti CF, Flanagan EP. Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder. JAMA Neurol. 2020 Dec 1; 77 (12):1575-1577
    View PubMed
  38. Lucchinetti CF, von Bormann AG, Nagel JJ, Jones AE, O'Horo JC, Callstrom MR, SMaRT Executive Committee. Engaging and Empowering the Front Lines During the COVID-19 Outpatient Practice Reactivation. Mayo Clin Proc. 2020 Sep; 95(9S):S47-S51. Epub 2020 Jun 30.
    View PubMed
  39. Kalinowska-Lyszczarz A, Fereidan-Esfahani M, Guo Y, Lucchinetti CF, Tobin WO. Pathological findings in central nervous system demyelination associated with infliximab. Mult Scler. 2020 Aug; 26 (9):1124-1129 Epub 2019 Dec 17
    View PubMed
  40. Chen JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, Dubey D, Lopez Chiriboga ASS, Fryer JP, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Lucchinetti CF, Kunchok A, McClelland CM, Lee MS, Bennett JL, Pelak VS, Van Stavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Lam BL, Moss H, Beres S, Gilbert AL, Shah V, Armstrong G, Heidary G, Cestari DM, Stiebel-Kalish H, Pittock SJ. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020 Jul 14; 95 (2):e111-e120 Epub 2020 June 17
    View PubMed
  41. Wilkins JM, Gakh O, Kabiraj P, McCarthy CB, Tobin WO, Howe CL, Lucchinetti CF. Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis. Aging (Albany NY). 2020 Jul 8; 12 (14):15134-15156 Epub 2020 July 08
    View PubMed
  42. Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020 Jul; 140 (1):1-6 Epub 2020 May 24
    View PubMed
  43. Hoftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, Joldic D, Pittock SJ, Tillema JM, Gorman M, Lassmann H, Lucchinetti CF. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 2020 May; 139 (5):875-892 Epub 2020 Feb 11
    View PubMed
  44. Ruegsegger GN, Vanderboom PM, Dasari S, Klaus KA, Kabiraj P, McCarthy CB, Lucchinetti CF, Nair KS. Exercise and metformin counteract altered mitochondrial function in the insulin-resistant brain. JCI Insight. 2019 Sep 19; 4(18).
    View PubMed
  45. Zekeridou A, Kryzer T, Guo Y, Hassan A, Lennon V, Lucchinetti CF, Pittock S, McKeon A. Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity. Neurology. 2019 Aug 20; 93 (8):e815-e822 Epub 2019 July 17
    View PubMed
  46. Eckel-Passow JE, Decker PA, Kosel ML, Kollmeyer TM, Molinaro AM, Rice T, Caron AA, Drucker KL, Praska CE, Pekmezci M, Hansen HM, McCoy LS, Bracci PM, Erickson BJ, Lucchinetti CF, Wiemels JL, Wiencke JK, Bondy ML, Melin B, Burns TC, Giannini C, Lachance DH, Wrensch MR, Jenkins RB. Using germline variants to estimate glioma and subtype risks. Neuro Oncol. 2019 Mar 18; 21 (4):451-461
    View PubMed
  47. Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol. 2019 Mar 1; 76 (3):301-309
    View PubMed
  48. Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP. Population-based study of "no evident disease activity" in MS. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5 (6):e495 Epub 2018 Aug 16
    View PubMed
  49. Chen JJ, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. Am J Ophthalmol. 2018 Nov; 195:8-15 Epub 2018 July 26
    View PubMed
  50. López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. JAMA Neurol. 2018 Nov 01; 75(11):1355-1363.
    View PubMed
  51. Basal E, Zalewski N, Kryzer TJ, Hinson SR, Guo Y, Dubey D, Benarroch EE, Lucchinetti CF, Pittock SJ, Lennon VA, McKeon A. Paraneoplastic neuronal intermediate filament autoimmunity. Neurology. 2018 Oct 30; 91 (18):e1677-e1689 Epub 2018 Oct 03
    View PubMed
  52. Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis. Ophthalmology. 2018 Oct; 125 (10):1628-1637 Epub 2018 Apr 30
    View PubMed
  53. Tillema JM, Weigand SD, Dayan M, Shu Y, Kantarci OH, Lucchinetti CF, Port JD. Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis. AJNR Am J Neuroradiol. 2018 Jun; 39 (6):1052-1058 Epub 2018 Apr 26
    View PubMed
  54. Marin Collazo IV, Howe CL, Lucchinetti CF, Tobin WO. Neuromyelitis Optica and Herpes Simplex Virus 2: A Viral Trigger for Aquaporin-4 Autoimmunity? Neurologist. 2018 May; 23 (3):92-93
    View PubMed
  55. Stork L, Ellenberger D, Beissbarth T, Friede T, Lucchinetti CF, Bruck W, Metz I. Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis. JAMA Neurol. 2018 Apr 1; 75 (4):428-435
    View PubMed
  56. Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. N Engl J Med. 2018 Jan 11; 378 (2):169-180
    View PubMed
  57. Parks NE, Flanagan EP, Lucchinetti CF, Wingerchuk DM. NEDA treatment target? No evident disease activity as an actionable outcome in practice. J Neurol Sci. 2017 Dec 15; 383:31-34 Epub 2017 Oct 13
    View PubMed
  58. Choi JH, Wallach AI, Rosales D, Margiewicz SE, Belmont HM, Lucchinetti CF, Minen MT. Clinical Reasoning: A 50-year-old woman with SLE and a tumefactive lesion. Neurology. 2017 Sep 19; 89 (12):e140-e145
    View PubMed
  59. Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017 Sep 1; 140 (9):2415-2425
    View PubMed
  60. Tobin WO, Costanzi C, Guo Y, Parisi JE, Weigand SD, Lucchinetti CF. Clinical-radiological-pathological spectrum of central nervous system-idiopathic inflammatory demyelinating disease in the elderly. Mult Scler. 2017 Aug; 23 (9):1204-1213 Epub 2016 Oct 19
    View PubMed
  61. Popescu BF, Frischer JM, Webb SM, Tham M, Adiele RC, Robinson CA, Fitz-Gibbon PD, Weigand SD, Metz I, Nehzati S, George GN, Pickering IJ, Bruck W, Hametner S, Lassmann H, Parisi JE, Yong G, Lucchinetti CF. Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions. Acta Neuropathol. 2017 Jul; 134 (1):45-64 Epub 2017 Mar 22
    View PubMed
  62. Tillema JM, Weigand SD, Mandrekar J, Shu Y, Lucchinetti CF, Pirko I, Port JD. In vivo detection of connectivity between cortical and white matter lesions in early MS. Mult Scler. 2017 Jun; 23 (7):973-981 Epub 2016 Oct 03
    View PubMed
  63. Guo Y, Weigand SD, Popescu BF, Lennon VA, Parisi JE, Pittock SJ, Parks NE, Clardy SL, Howe CL, Lucchinetti CF. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica. Acta Neuropathol. 2017 Apr; 133 (4):597-612 Epub 2017 Feb 09
    View PubMed
  64. Zalewski NL, Morris PP, Weinshenker BG, Lucchinetti CF, Guo Y, Pittock SJ, Krecke KN, Kaufmann TJ, Wingerchuk DM, Kumar N, Flanagan EP. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2017 Mar; 88 (3):218-225 Epub 2016 Dec 02
    View PubMed
  65. Wang Y, Cao Y, Mangalam AK, Guo Y, LaFrance-Corey RG, Gamez JD, Atanga PA, Clarkson BD, Zhang Y, Wang E, Angom RS, Dutta K, Ji B, Pirko I, Lucchinetti CF, Howe CL, Mukhopadhyay D. Neuropilin-1 modulates interferon-?-stimulated signaling in brain microvascular endothelial cells. J Cell Sci. 2016 Oct 15; 129(20):3911-3921. Epub 2016 Sep 02.
    View PubMed
  66. Russi AE, Walker-Caulfield ME, Guo Y, Lucchinetti CF, Brown MA. Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity. J Autoimmun. 2016 Sep; 73:100-10 Epub 2016 July 05
    View PubMed
  67. Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology. 2016 Aug 30; 87: (9 Suppl 2)S38-45.
    View PubMed
  68. Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol. 2016 Aug; 15 (9):967-981
    View PubMed
  69. Chuang TY, Guo Y, Seki SM, Rosen AM, Johanson DM, Mandell JW, Lucchinetti CF, Gaultier A. LRP1 expression in microglia is protective during CNS autoimmunity. Acta Neuropathol Commun. 2016 Jul 11; 4 (1):68 Epub 2016 July 11
    View PubMed
  70. Hardy TA, Tobin WO, Lucchinetti CF. Exploring the overlap between multiple sclerosis, tumefactive demyelination and Balo's concentric sclerosis. Mult Scler. 2016 Jul; 22 (8):986-92 Epub 2016 Apr 01
    View PubMed
  71. Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, St Sauver J, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Robinson AB, Pittock SJ. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol. 2016 May; 79 (5):775-783 Epub 2016 Apr 04
    View PubMed
  72. Tobin WO, Popescu BF, Lowe V, Pirko I, Parisi JE, Kantarci K, Fields JA, Bruns MB, Boeve BF, Lucchinetti CF. Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings. Mult Scler. 2016 Apr; 22 (5):698-704 Epub 2015 Oct 07
    View PubMed
  73. Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E. Relapses in multiple sclerosis: Relationship to disability. Mult Scler Relat Disord. 2016 Mar; 6:10-20 Epub 2015 Sept 08
    View PubMed
  74. Pittock SJ, Lucchinetti CF. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci. 2016 Feb; 1366 (1):20-39 Epub 2015 June 10
    View PubMed
  75. Popescu BF, Lucchinetti CF. Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis. Handb Clin Neurol. 2016; 133:95-106.
    View PubMed
  76. Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Bruck W, Lassmann H, Lucchinetti CF. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol. 2015 Nov; 78 (5):710-21 Epub 2015 Aug 24
    View PubMed
  77. Walker-Caulfield ME, Guo Y, Johnson RK, McCarthy CB, Fitz-Gibbon PD, Lucchinetti CF, Howe CL. NF?B signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG. J Neuroinflammation. 2015 Sep 30; 12:185.
    View PubMed
  78. Novotna M, Paz Soldan MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis. Neurology. 2015 Aug 25; 85 (8):722-9 Epub 2015 July 24
    View PubMed
  79. Ransohoff RM, Hafler DA, Lucchinetti CF. Multiple sclerosis-a quiet revolution. Nat Rev Neurol. 2015 Mar; 11 (3):134-42 Epub 2015 Feb 17
    View PubMed
  80. Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Bruck W, Shuster EA, Carter J, Boyd CD, Clardy SL, Cohen BA, Lucchinetti CF. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions. Neurology. 2015 Jan 13; 84 (2):148-58 Epub 2014 Dec 10
    View PubMed
  81. Paz Soldan MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH. Relapses and disability accumulation in progressive multiple sclerosis. Neurology. 2015 Jan 6; 84 (1):81-8 Epub 2014 Nov 14
    View PubMed
  82. Pfeifenbring S, Bunyan RF, Metz I, Rover C, Huppke P, Gartner J, Lucchinetti CF, Bruck W. Extensive acute axonal damage in pediatric multiple sclerosis lesions. Ann Neurol. 2015; 77(4):655-67.
    View PubMed
  83. Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015 Jan; 72 (1):81-7
    View PubMed
  84. Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014 Nov 11; 83 (20):1797-803 Epub 2014 Oct 15
    View PubMed
  85. Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang MH, Chen AP, Kryzer TJ, Fryer JP, Jenkins SM, Cabre P, Lennon VA. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. Lancet Neurol. 2014 Aug; 13 (8):795-806 Epub 2014 July 06
    View PubMed
  86. Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D, Balabanov R, Lucchinetti CF. Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. JAMA Neurol. 2014 Aug; 71(8):1025-9.
    View PubMed
  87. Fryer JP, Lennon VA, Pittock SJ, Jenkins SM, Fallier-Becker P, Clardy SL, Horta E, Jedynak EA, Lucchinetti CF, Shuster EA, Weinshenker BG, Wingerchuk DM, McKeon A. AQP4 autoantibody assay performance in clinical laboratory service. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1 (1):e11 Epub 2014 May 22
    View PubMed
  88. Tobin WO, Weinshenker BG, Lucchinetti CF. Longitudinally extensive transverse myelitis. Curr Opin Neurol. 2014 Jun; 27 (3):279-89
    View PubMed
  89. Clardy SL, Lucchinetti CF, Krecke KN, Lennon VA, O'Toole O, Weinshenker BG, Boyd CD, Krieger S, McGraw C, Guo Y, Pittock SJ. Hydrocephalus in neuromyelitis optica. Neurology. 2014 May 20; 82 (20):1841-3 Epub 2014 Apr 23
    View PubMed
  90. Robinson CA, Adiele RC, Tham M, Lucchinetti CF, Popescu BFGh. Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis. Acta Neuropathologica Communications. 2014 May 8; 2(1):52.
  91. Howe CL, Kaptzan T, Magaña SM, Ayers-Ringler JR, LaFrance-Corey RG, Lucchinetti CF. Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures. Glia. 2014 May; 62(5):692-708. Epub 2014 Feb 03.
    View PubMed
  92. Metz I, Weigand SD, Popescu BF, Stadelmann C, Frischer JM, Parisi JE, Guo Y, Lassmann H, Brück W, Lucchinetti CF. Immunopathologic Heterogeneity Persists in Early Active Multiple Sclerosis Lesions. Ann Neurol. 2014 Apr 22; 75:728-38.
  93. Figueroa M, Guo Y, Tselis A, Pittock SJ, Lennon VA, Lucchinetti CF, Lisak RP. Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. JAMA Neurol. 2014 Apr; 71 (4):495-8
    View PubMed
  94. Gh Popescu BF, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF. Evidence of aquaporin involvement in human central pontine myelinolysis Acta Neuropathologica Communications. 2014; 2: (1)40.
  95. Metz I, Weigand SD, Popescu BFG, Frischer JM, Parisi JE, Guo Y, Lassmann H, Bruck W, Lucchinetti CF. Pathologic heterogeneity persists in early active multiple sclerosis lesions. Ann Neurol. 2014; 75(5):728-38.
    View PubMed
  96. Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol. 2014 Jan; 24 (1):83-97
    View PubMed
  97. Jiao Y, Fryer JP, Lennon VA, McKeon A, Jenkins SM, Smith CY, Quek AM, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol. 2014 Jan; 71 (1):48-54
    View PubMed
  98. Wuthrich C, Popescu BF, Gheuens S, Marvi M, Ziman R, Denq SP, Tham M, Norton E, Parisi JE, Dang X, Lucchinetti CF, Koralnik IJ. Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study. J Neuropathol Exp Neurol. 2013 Nov; 72 (11):1043-51
    View PubMed
  99. Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, McKeon A, Costanzi C, Iorio R, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013 Oct 1; 81 (14):1197-204 Epub 2013 Aug 30
    View PubMed
  100. Popescu BF, Pirko I, Lucchinetti CF. Pathology of multiple sclerosis: where do we stand? Continuum (Minneap Minn). 2013 Aug; 19 (4 Multiple Sclerosis):901-21
    View PubMed
  101. Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O'Toole O, Wingerchuk DM. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013 Jun; 12(6):554-62. Epub 2013 Apr 26.
    View PubMed
  102. Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, Pittock SJ. Intractable nausea and vomiting from autoantibodies against a brain water channel. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):240-5. Epub 2012 Dec 01.
    View PubMed
  103. Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler. 2013 Feb; 19 (2):188-98 Epub 2012 June 26
    View PubMed
  104. Popescu BF, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF. Evidence of aquaporin involvement in human central pontine myelinolysis. Acta Neuropathol Commun. 2013; 1(1):40. Epub 2013 Jul 25
    View PubMed
  105. Cook SD, Dhib-Jalbut S, Dowling P, Durelli L, Ford C, Giovannoni G, Halper J, Harris C, Herbert J, Li D, Lincoln JA, Lisak R, Lublin FD, Lucchinetti CF, Moore W, Naismith RT, Oehninger C, Simon J, Sormani MP. Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010. Int J MS Care. 2012 Fall; 14 (3):105-14
    View PubMed
  106. Bruck W, Popescu B, Lucchinetti CF, Markovic-Plese S, Gold R, Thal DR, Metz I. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate. Ann Neurol. 2012 Sep; 72(3):385-94.
    View PubMed
  107. Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y, Costanzi C, Weinshenker BG, Wingerchuk DM, Lucchinetti CF, Shuster EA, Pittock SJ. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol. 2012 Aug; 69 (8):1039-43
    View PubMed
  108. Abou Zeid N, Pirko I, Erickson B, Weigand SD, Thomsen KM, Scheithauer B, Parisi JE, Giannini C, Linbo L, Lucchinetti CF. Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions. Neurology. 2012 May 22; 78 (21):1655-62 Epub 2012 May 09
    View PubMed
  109. Filippi M, Rocca MA, Barkhof F, Bruck W, Chen JT, Comi G, DeLuca G, De Stefano N, Erickson BJ, Evangelou N, Fazekas F, Geurts JJ, Lucchinetti C, Miller DH, Pelletier D, Popescu BF, Lassmann H, Attendees of the Correlation between Pathological MRI findings in MS workshop. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 2012 Apr; 11(4):349-60. Epub 2012 Mar 19.
    View PubMed
  110. Costanzi C, Bourdette D, Parisi JE, Woltjer R, Rodriguez F, Steensma D, Lucchinetti CF. Crystal-storing histiocytosis: An unusual relapsing inflammatory CNS disorder. Mult Scler Relat Disord. 2012 Apr; 1 (2):95-9 Epub 2012 Jan 27
    View PubMed
  111. Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, Fallier-Becker P, Noell S, Lennon VA. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci U S A. 2012 Jan 24; 109 (4):1245-50 Epub 2011 Nov 29
    View PubMed
  112. Popescu BF, Lucchinetti CF. Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol. 2012; 12:11. Epub 2012 Mar 07.
    View PubMed
  113. Popescu BF, Lucchinetti CF. Pathology of demyelinating diseases. Annu Rev Pathol. 2012; 7:185-217.
    View PubMed
  114. Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Bruck W, Parisi JE, Scheithauer BW, Giannini C, Weigand SD, Mandrekar J, Ransohoff RM. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med. 2011 Dec 8; 365 (23):2188-97
    View PubMed
  115. Iorio R, Lucchinetti CF, Lennon VA, Costanzi C, Hinson S, Weinshenker BG, Pittock SJ. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology. 2011 Oct 25; 77 (17):1644-6 Epub 2011 Oct 12
    View PubMed
  116. Costanzi C, Matiello M, Lucchinetti CF, Weinshenker BG, Pittock SJ, Mandrekar J, Thapa P, McKeon A. Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica. Neurology. 2011 Aug 16; 77 (7):659-66 Epub 2011 Aug 03
    View PubMed
  117. Smith JH, Dhamija R, Moseley BD, Sandroni P, Lucchinetti CF, Lennon VA, Kantarci OH. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Arch Neurol. 2011 Aug; 68(8):1069-72.
    View PubMed
  118. Magana SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J, Linbo L, Lucchinetti CF. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol. 2011 Jul; 68 (7):870-8 Epub 2011 Mar 14
    View PubMed
  119. Roemer SF, Scheithauer BW, Varnavas GG, Lucchinetti CF. Tumefactive demyelination and glioblastoma: a rare collision lesion. Clin Neuropathol. 2011 Jul-Aug; 30 (4):186-91
    View PubMed
  120. Popescu BF, Bunyan RF, Parisi JE, Ransohoff RM, Lucchinetti CF. A case of multiple sclerosis presenting with inflammatory cortical demyelination. Neurology. 2011 May 17; 76 (20):1705-10
    View PubMed
  121. Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology. 2011 Apr 5; 76 (14):1229-37 Epub 2011 Mar 02
    View PubMed
  122. Almekhlafi MA, Clark AW, Lucchinetti CF, Zhang Y, Power C, Bell RB. Neuromyelitis optica with extensive active brain involvement: an autopsy study. Arch Neurol. 2011 Apr; 68(4):508-12.
    View PubMed
  123. Bunyan RF, Popescu BF, Carter JL, Caselli RJ, Parisi JE, Lucchinetti CF. Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination. Arch Neurol. 2011 Apr; 68 (4):525-8
    View PubMed
  124. Jones DT, Mateen FJ, Lucchinetti CF, Jack CR Jr, Welker KM. Default mode network disruption secondary to a lesion in the anterior thalamus. Arch Neurol. 2011 Feb; 68 (2):242-7 Epub 2010 Oct 11
    View PubMed
  125. Popescu BF, Parisi JE, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Lennon VA, Weinshenker BG, Lucchinetti CF. Absence of cortical demyelination in neuromyelitis optica. Neurology. 2010 Dec 7; 75 (23):2103-9
    View PubMed
  126. Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, McKeon A, Carpenter AF, Miller GM, Pittock SJ. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010 Nov; 68 (5):757-61
    View PubMed
  127. Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sorensen PS, Laursen H. Demyelination versus remyelination in progressive multiple sclerosis. Brain. 2010 Oct; 133(10):2983-98. Epub 2010 Sep 20.
    View PubMed
  128. Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010 Sep; 67(9):1109-15.
    View PubMed
  129. Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, Thomsen KM, Mandrekar JN, Erickson BJ, Lucchinetti CF. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain. 2010 Feb; 133 (Pt 2):333-48 Epub 2010 Feb 03
    View PubMed
  130. Hu W, Lucchinetti CF. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol. 2009 Nov; 31 (4):439-53 Epub 2009 Sept 25
    View PubMed
  131. Staff NP, Lucchinetti CF, Keegan BM. Multiple sclerosis with predominant, severe cognitive impairment. Arch Neurol. 2009 Sep; 66 (9):1139-43
    View PubMed
  132. McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol. 2009 Sep; 66 (9):1134-8
    View PubMed
  133. Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol. 2009 Sep; 66 (9):1128-33
    View PubMed
  134. Magana SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol. 2009 Aug; 66 (8):964-6
    View PubMed
  135. Daniels TB, Pollock BE, Miller RC, Lucchinetti CF, Leavitt JA, Brown PD. Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report. J Neurooncol. 2009 Jun; 93 (2):263-7 Epub 2008 Dec 20
    View PubMed
  136. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009 May; 132(Pt 5):1175-89. Epub 2009 Mar 31.
    View PubMed
  137. Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 2009 Feb 24; 72(8):712-7.
    View PubMed
  138. McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve. 2009 Jan; 39(1):87-90.
    View PubMed
  139. Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, Cohen IR, Weiner HL. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A. 2008 Dec 2; 105(48):18889-94. Epub 2008 Nov 21.
    View PubMed
  140. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008 Oct 27; 205 (11):2473-81 Epub 2008 Oct 06
    View PubMed
  141. Rodriguez FJ, Gamez JD, Vrana JA, Theis JD, Giannini C, Scheithauer BW, Parisi JE, Lucchinetti CF, Pendlebury WW, Bergen HR 3rd, Dogan A. Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissues. Lab Invest. 2008 Oct; 88 (10):1024-37 Epub 2008 Aug 18
    View PubMed
  142. McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ. CNS aquaporin-4 autoimmunity in children. Neurology. 2008 Jul 8; 71 (2):93-100 Epub 2008 May 28
    View PubMed
  143. Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ, Konig F, Giannini C, Lassmann H, Linbo L, Pittock SJ, Bruck W. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008 Jul; 131 (Pt 7):1759-75 Epub 2008 June 05
    View PubMed
  144. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008 Jun 3; 70(23):2197-200. Epub 2008 Apr 23.
    View PubMed
  145. Scarisbrick IA, Linbo R, Vandell AG, Keegan M, Blaber SI, Blaber M, Sneve D, Lucchinetti CF, Rodriguez M, Diamandis EP. Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biol Chem. 2008 Jun; 389 (6):739-45
    View PubMed
  146. Porter AB, Giannini C, Kaufmann T, Lucchinetti CF, Wu W, Decker PA, Atkinson JL, O'Neill BP. Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Ann Neurol. 2008 May; 63 (5):662-7
    View PubMed
  147. Keegan BM, Giannini C, Parisi JE, Lucchinetti CF, Boeve BF, Josephs KA. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology. 2008 Mar 25; 70(13 Pt 2):1128-33. Epub 2008 Feb 20.
    View PubMed
  148. Young NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol. 2008 Feb; 28 (1):84-94
    View PubMed
  149. Lucchinetti CF. Multiple sclerosis and the spectrum of CNS inflammatory demyelinating diseases. Semin Neurol. 2008 Feb; 28(1):3-6.
    View PubMed
  150. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology. 2008 Jan 29; 70(5):344-52. Epub 2007 Dec 19
    View PubMed
  151. Lucchinetti C. Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders. Curr Top Microbiol Immunol. 2008; 318:19-43
    View PubMed
  152. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol. 2008 Jan; 65 (1):78-83
    View PubMed
  153. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007 Dec 11; 69 (24):2221-31 Epub 2007 Oct 10
    View PubMed
  154. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 Sep; 6 (9):805-15
    View PubMed
  155. Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG. Neuromyelitis optica: changing concepts. J Neuroimmunol. 2007 Jul; 187(1-2):126-38. Epub 2007 May 21.
    View PubMed
  156. Wingerchuk DM, Lucchinetti CF. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol. 2007 Jun; 20(3):343-50.
    View PubMed
  157. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007 May; 130 (Pt 5):1194-205 Epub 2007 Feb 04
    View PubMed
  158. Metz I, Lucchinetti CF, Openshaw H, Garcia-Merino A, Lassmann H, Freedman MS, Atkins HL, Azzarelli B, Kolar OJ, Bruck W. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain. 2007 May; 130(Pt 5):1254-62.
    View PubMed
  159. Vana AC, Lucchinetti CF, Le TQ, Armstrong RC. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS. Glia. 2007 May; 55(7):687-97.
    View PubMed
  160. Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007 Apr; 17(2):210-8.
    View PubMed
  161. Pittock SJ, Lucchinetti CF. The pathology of MS: new insights and potential clinical applications. Neurologist. 2007 Mar; 13(2):45-56.
    View PubMed
  162. Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology. 2007 Feb 27; 68(9):634-42.
    View PubMed
  163. Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology. 2007 Feb 20; 68 (8):603-5
    View PubMed
  164. Lucchinetti CF. Advances in the neuropathology of multiple sclerosis: Evolving pathogenic insights. CONTINUUM Lifelong Learn. Neurol. 2007; 13(5 MULTIPL.SCLEROSIS):86-116.
  165. Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, Stadelmann C, Bruck W, Rauschka H, Schmidbauer M, Lassmann H. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol. 2007 Jan; 17(1):38-44.
    View PubMed
  166. Hu WT, Kantarci OH, Merritt JL, McGrann P, Dyck PJ, Lucchinetti CF, Tippmann-Peikert M. Ornithine transcarbamylase deficiency presenting as encephalopathy during adulthood following bariatric surgery. Arch Neurol. 2007 Jan; 64(1):126-8.
    View PubMed
  167. Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult Scler. 2007 Jan; 13: (1)7-16.
    View PubMed
  168. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006 Dec; 129(Pt 12):3165-72. Epub 2006 Aug 18.
    View PubMed
  169. Miller RC, Lachance DH, Lucchinetti CF, Keegan BM, Gavrilova RH, Brown PD, Weinshenker BG, Rodriguez M. Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1178-86. Epub 2006 Sep 11.
    View PubMed
  170. Pittock SJ, Lucchinetti CF. Inflammatory transverse myelitis: evolving concepts. Curr Opin Neurol. 2006 Aug; 19 (4):362-8
    View PubMed
  171. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 Jul; 63 (7):964-8
    View PubMed
  172. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 May 23; 66 (10):1485-9
    View PubMed
  173. Schwartz KM, Erickson BJ, Lucchinetti C. Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology. 2006 Mar; 48 (3):143-9 Epub 2006 Jan 31
    View PubMed
  174. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 Mar; 63 (3):390-6
    View PubMed
  175. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 Mar; 59 (3):566-9
    View PubMed
  176. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb; 63 (2):197-202
    View PubMed
  177. Fox RJ, Kivisakk P, Lee JC, Tucky B, Lucchinetti C, Rudick RA, Ransohoff RM. Chemokine receptors as biomarkers in multiple sclerosis. Dis Markers. 2006; 22(4):227-33.
    View PubMed
  178. Weinshenker BG, Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA. NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers. 2006; 22 (4):197-206
    View PubMed
  179. Morales Y, Parisi JE, Lucchinetti CF. The pathology of multiple sclerosis: evidence for heterogeneity. Adv Neurol. 2006; 98:27-45.
    View PubMed
  180. Kantarci OH, Morales Y, Ziemer PA, Hebrink DD, Mahad DJ, Atkinson EJ, Achenbach SJ, De Andrade M, Mack M, Ransohoff RM, Lassmann H, Bruck W, Weinshenker BG, Lucchinetti CF. CCR5 Delta 32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. J Neuroimmunol. 2005 Dec; 169(1-2):137-43 Epub 2005 Sep 22.
    View PubMed
  181. Pittock SJ, McClelland RL, Achenbach SJ, Konig F, Bitsch A, Bruck W, Lassmann H, Parisi JE, Scheithauer BW, Rodriguez M, Weinshenker BG, Lucchinetti CF. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry. 2005 Dec; 76 (12):1693-7
    View PubMed
  182. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005 Nov; 128(Part 11):2705-12.
    View PubMed
  183. Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, Cree BAC, Hauser S, Racke MK. Characterizing the mechanisms of progression in multiple sclerosis - Evidence and new hypotheses for future directions. Arch Neurol. 2005 Sep; 62(9):1345-56.
    View PubMed
  184. Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet. 2005 Aug 13-19; 366(9485):579-82.
    View PubMed
  185. Cox A, Coles A, Antoun N, Malik O, Lucchinnetti C, Compston A. Recurrent myelitis and optic neuritis in a 29-year-old woman. Lancet Neurol. 2005 Aug; 4(8):510-6.
    View PubMed
  186. Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Kilimann MW, Lennon VA. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005 Jul; 58(1):96-107.
    View PubMed
  187. Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, Leel-Ossy L, Ordinario AT, Bruck W, Lassmann H. Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis. Brain. 2005 May; 128(Part 5):979-87.
    View PubMed
  188. Wingerchuk DM, Benarroch EE, O'Brien PC, Keegan BM, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology. 2005 Apr 12; 64(7):1267-9.
    View PubMed
  189. Lucchinetti CF. Update on the international project on pathologic correlates in MS. Mult Scler. 2005 Feb; 11: (1)99-100.
    View PubMed
  190. Lucchinetti CF, Parisi J, Bruck W. The pathology of multiple sclerosis. Neurol Clin. 2005 Feb; 23(1):77-105.
    View PubMed
  191. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 Dec 11-17; 364 (9451):2106-12
    View PubMed
  192. Lucchinetti C, Bruck W. The pathology of primary progressive multiple sclerosis. Mult Scler. 2004 Jun; 10 Suppl 1:S23-30
    View PubMed
  193. Mahad DJ, Trebst C, Kivisakk P, Staugaitis SM, Tucky B, Wei T, Lucchinetti CF, Lassmann H, Ransohoff RM. Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions. J Neuropathol Exp Neurol. 2004 Mar; 63(3):262-73.
    View PubMed
  194. Hoftberger R, Aboul-Enein F, Brueck W, Lucchinetti C, Rodriguez M, Schmidbauer M, Jellinger K, Lassmann H. Expression of major histocompatibility complex Class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 2004 Jan; 14(1):43-50.
    View PubMed
  195. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments. Ann Neurol 2003 May; 53(5):580-7.
    View PubMed
  196. Trebst C, Staugaitis SM, Kivisakk P, Mahad D, Cathcart MK, Tucky B, Wei T, Rani MRS, Horuk R, Aldape KD, Pardo CA, Lucchinetti CF, Lassmann H, Ransohoff RM. CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages. Am J Pathol. 2003 Feb; 162(2):427-38.
    View PubMed
  197. Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. Journal of Neuropathology & Experimental Neurology. 2003 Jan; 62(1):25-33.
    View PubMed
  198. O’Connor P, Fleming P, Gray T, Jacobs L, Miller C, Munschauer F, Kinkel RP, Bolibrush D, Cohen J, Freedman M, Webb U, Rabinowicz H, Metz LM, Patry D, Yeung M, Peters S, Hashimoto S, Morrison W, Oger J, Panitch H, Costello K, Bever C, Stuart W, Court D, Stuart D, Simon J, Lucchinetti CF, Carter J, et al. MRI predictors of early conversion to clinically definite MS in the CHAMPS Placebo Group. Neurology. 2002 Oct 8; 59: (7)998-1005.
    View PubMed
  199. O’Connor P, Fleming P, Gray T, Jacobs L, Miller C, Munschaner F, Kinkel RP, Bolibrush D, Cohen J, Freedman M, Webb U, Rabinowicz H, Metz LM, Patry D, Yeung M, Peters S, Hashimoto S, Morrison W, Oger J, Panitch H, Costello K, Bever C, Stuart W, Court D, Stuart D, Beck R, Lucchinetti CF, et al. Predictors of short-term disease activity following a first clinical demyelinating event: Analysis of the CHAMPS Placebo Group. Mult Scler. 2002 Oct;8(5):405-9.
    View PubMed
  200. Lucchinetti CF. Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial. Controlled High-Risk Subjects Avonex Multiple Sclerosis Prevention Study. Mult Scler. 2002 Aug; 8: (4)330-8.
    View PubMed
  201. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002 Jul; 125 (Pt 7):1450-61
    View PubMed
  202. Scarisbrick IA, Blaber SI, Lucchinetti CF, Genain CP, Blaber M, Rodriguez M, Rodriguez M. Activity of a newly identified serine protease in CNS demyelination. Brain. 2002 Jun; 125 (Pt 6):1283-96
    View PubMed
  203. Bruck W, Lucchinetti C, Lassmann H. The pathology of primary progressive multiple sclerosis. Mult Scler. 2002 Apr; 8(2):93-7.
    View PubMed
  204. Scarisbrick IA, Blaber SI, Lucchinetti CF, Genain CP, Blaber M, Rodriguez M. Activity of a newly identified serine protease in immune-mediated demyelination. Brain. 2002; 125:1-14.
  205. Martinez-Arizala A, Barnes G, Benjamin S, Bowen J, Cutter N, Dietrich D, Dowling M, Griffin J, Irani D, Jorens P, Kaplin A, Katz J, Kerr D, Levy C, Lucchinetti CF, Lynn J, Mandler R, McDonald J, Morrison L, Pardo C, Pidcock F, Ransohoff R, Trovato M, Wegener S, Weinshenker B, Wingerchuk D, Vollmer T. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002:499-505.
  206. Targonski PV, Schiebel NE, Lucchinetti CN. Minocyoline-associated idiopathic intracranial hypertension in a patient presenting to the emergency department. Internet Journal of Emergency & Intensive Care Medicine. 2002; 6(1):8p.
  207. CHAMPS Study Group. Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol. 2001 Oct; 132 (4):463-71
    View PubMed
  208. Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Bruck W. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol. 2001 Jun; 49(6):793-6.
    View PubMed
  209. Lucchinetti C, Bruck W, Lucchinetti C, Noseworthy J, Noseworthy J. Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr Opin Neurol. 2001 Jun; 14 (3):259-69
    View PubMed
  210. Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med. 2001 Mar; 7(3):115-21.
    View PubMed
  211. Wingerchuk DM, Lucchinetti CF, Noseworthy JH. Multiple sclerosis: current pathophysiological concepts. Lab Invest. 2001 Mar; 81 (3):263-81
    View PubMed
  212. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000 Sep 28; 343 (13):938-52
    View PubMed
  213. Lucchinetti C, Bruck W, Lucchinetti C, Parisi J, Parisi J, Scheithauer B, Rodriguez M, Lassmann H, Rodriguez M. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000 Jun; 47 (6):707-17
    View PubMed
  214. Eggenberger ER, Lucchinetti CF. Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update. Arch Ophthalmol. 2000 Jun; 118: (6)793-8.
    View PubMed
  215. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M, Rodriguez M. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999 Dec; 46 (6):878-86
    View PubMed
  216. Lucchinetti C, Bruck W, Lucchinetti C, Parisi J, Parisi J, Scheithauer B, Rodriguez M, Lassmann H, Rodriguez M. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain. 1999 Dec; 122 ( Pt 12):2279-95
    View PubMed
  217. Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Bruck W. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia. 1999 Oct; 28(1):34-9.
    View PubMed
  218. Auger RG, Windebank AJ, Lucchinetti CF, Chalk CH. Role of the blink reflex in the evaluation of sensory neuronopathy. Neurology. 1999 Jul 22; 53 (2):407-8
    View PubMed
  219. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest. 1999 Mar; 103(6):807-15.
    View PubMed
  220. Drescher KM, Rivera-Quinones C, Lucchinetti CF, Rodriguez M. Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis. J Neuroimmunol. 1998 Aug 1; 88(1-2):111-9.
    View PubMed
  221. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998 Mar; 50 (3):652-7
    View PubMed
  222. Petty GW, Engel AG, Younge BR, Duffy J, Yanagihara T, Lucchinetti CF, Bartleson JD, Parisi JE, Kasperbauer JL, Rodriguez M, Rodriguez M. Retinocochleocerebral vasculopathy. Medicine (Baltimore). 1998 Jan; 77 (1):12-40
    View PubMed
  223. Weinshenker BG, Lucchinetti CF. Acute leukoencephalopathies: differential diagnosis and investigation. Neurologist. 1998; 4(3):148-66.
  224. Lucchinetti CF, Brueck W, Rodriguez M, Lassmann H. Multiple sclerosis: lessons from neuropathology. Semin Neurol. 1998; 18(3):337-49.
    View PubMed
  225. Lucchinetti CF, Kiers L, O'Duffy A, Gomez MR, Cross S, Cross S, Leavitt JA, O'Brien P, Rodriguez M, O'Brien P, Rodriguez M. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology. 1997 Nov; 49 (5):1413-8
    View PubMed
  226. Lucchinetti CF, Kimmel DW, Pavelko K, Rodriguez M. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus. Exp Neurol. 1997 Sep; 147(1):123-9.
    View PubMed
  227. Lucchinetti CF, Rodriguez M. The controversy surrounding the pathogenesis of the multiple sclerosis lesion. Mayo Clin Proc. 1997 Jul; 72(7):665-78.
    View PubMed
  228. Lassmann H, Bruck W, Lucchinetti C, Rodriguez M. Remyelination in multiple sclerosis. Mult Scler. 1997 Apr; 3(2):133-6.
    View PubMed
  229. Lucchinetti CF, Noseworthy JH, Rodriguez M. Promotion of endogenous remyelination in multiple sclerosis. Mult Scler. 1997 Apr; 3: (2)71-5.
    View PubMed
  230. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H, Rodriguez M. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 1996 Jul; 6 (3):259-74
    View PubMed
  231. Kerns JM, Lucchinetti C. Electrical field effects on crushed nerve regeneration. Exp Neurol. 1992 Jul; 117(1):71-80.
    View PubMed
  232. Kerns JM, Braverman B, Mathew A, Lucchinetti C, Ivankovich AD. A comparison of cryoprobe and crush lesions in the rat sciatic nerve. Pain. 1991 Oct; 47(1):31-9.
    View PubMed
  233. Rodriguez M, Lucchinetti CF, Clark RJ, Yakash TL, Markowitz H, Lennon VA. Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. J Immunol. 1988 Feb 1; 140(3):800-6.
    View PubMed